Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans
Cinzia Magagnotti
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorFederica Orsi
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorRenzo Bagnati
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorNicola Celli
Center for Environmental Health “G. Paone”, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy
Search for more papers by this authorDomenico Rotilio
Center for Environmental Health “G. Paone”, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy
Search for more papers by this authorRoberto Fanelli
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorCorresponding Author
Luisa Airoldi
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy. Fax: 39 02 3546277Search for more papers by this authorCinzia Magagnotti
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorFederica Orsi
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorRenzo Bagnati
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorNicola Celli
Center for Environmental Health “G. Paone”, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy
Search for more papers by this authorDomenico Rotilio
Center for Environmental Health “G. Paone”, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy
Search for more papers by this authorRoberto Fanelli
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Search for more papers by this authorCorresponding Author
Luisa Airoldi
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy. Fax: 39 02 3546277Search for more papers by this authorAbstract
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is the most abundant heterocyclic amine formed in meat and fish during cooking and can be used as a model compound for this class of chemicals possibly involved in human carcinogenesis. Knowing the exposure to heterocyclic amines is important for establishing their role in human diseases. Serum albumin (SA) and globin (Gb) adducts were first tested as biomarkers of exposure to PhIP in male Fischer 344 rats given oral doses of 0.1, 0.5, 1 and 10 mg/kg. Blood samples were collected 24 hr after treatment and PhIP released from SA and Gb after acidic hydrolysis was analyzed by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry. PhIP-SA and Gb adducts increased linearly with the dose. Studies on 35 volunteers with different dietary habits exhibited that diet was a major determinant in the formation of both adducts. PhIP-SA adducts were significantly higher in meat consumers than in vegetarians (6.7 ± 1.6 and 0.7 ± 0.3 fmol/mg SA; respectively, mean ± SE; p = 0.04, Mann-Whitney U test). The Gb adduct pattern was quantitatively lower but paralleled SA (3 ± 0.8 in meat consumers and 0.3 ± 0.1 in vegetarians). PhIP-SA adducts were no different in smokers and in non-smokers. The results show for the first time that PhIP-blood protein adducts are present in humans not given the synthetic compound. Both biomarkers appear to be suitable for assessing dietary exposure and internal PhIP dose and may be promising tools for studying the role of heterocyclic amines in the etiology of colon cancer and other diseases. Int. J. Cancer 88:1–6, 2000. © 2000 Wiley-Liss, Inc.
REFERENCES
- Alexander, J., Reistad, R., Frandsen, H. and Grivas, S., Binding of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to protein- and low molecular weight thiols and its role in ring hydroxylation. Mutat. Res., 376, 7-12 (1997).
- Augustsson, K., Skog, K., Jagerstad, M., Dickman, P.W. and Steineck, G., Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet, 353, 703-707 (1999).
- Augustsson, K., Skog, K., Jagerstad, M. and Steineck, G., Assessment of the human exposure to heterocyclic amines. Carcinogenesis, 18, 1931-1935 (1997).
- Baker, H.J., Lindsey, J.R. and Weisbroth, S.H., The laboratory rat, vol 1, Biology and disease. Academic Press, New York (1979).
- Bonfanti, M., Magagnotti, C., Galli, A., Bagnati, R., Moret, M., Gariboldi, P., Fanelli, R. and Airoldi, L., Determination of O6-butylguanine in DNA by immunoaffinity extraction/gas chromatography-mass spectrometry. Cancer Res., 50 , 6870-6875 (1990).
- Boobis, A.R., Lynch, A.M., Murray, S., De La Torre, R., Solans, A., Farré, M., Segura, J., Gooderham, N.J. and Davies, D.S., CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res., 54, 89-94 (1994).
- Byrne, C., Sinha, R., Platz, E.A., Giovannucci, E., Colditz, G.A., Hunter, D.J., Speizer, F.E. and Willett, W.C., Predictors of dietary heterocyclic amine intake in three prospective cohorts. Cancer Epidemiol. Biomarkers Prev., 7, 523-529 (1998).
- Crofts, F.G., Strickland, P.T., Hayes, C.L. and Sutter, T.R., Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome p4501B1. Carcinogenesis, 18, 1793-1798 (1997).
- Davis, C.D., Schut, H.A.J. and Snyderwine, E.G., Enzymatic phase-II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis, 14 , 2091-2096 (1993).
- Dingley, K.H., Curtis, K., Nowell, S., Felton, J.S., Lang, N.P. and Tureltaub, K.W., DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol. Biomarkers Prev., 8, 507-512 (1999).
- Dingley, K.H., Freeman, S.P., Nelson, D.O., Garner, R.C. and Turteltaub, K.W., Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats. Drug Metab. Disp., 26, 825-828 (1998).
- Doll, R. and Peto, R., The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. nat. Cancer Inst., 66, 1191-1308 (1981).
- Englard, S. and Seifter, S. Precipitation techniques. In M.P. Deutscher (ed.), Guide to protein purification. pp. 285-300. Academic Press, San Diego. Methods in Enzymology. 1990).
- Gooderham, N.J., Murray, S., Lynch, A.M., Yadollahi-Farsani, M., Zhao, K., Rich, K., Boobis, A.R. and Davies, D.S., Assessing human risk to heterocyclic amines. Mutat.Res., 376, 53-60 (1997).
- Hammons, G.J., Milton, D., Stepps, K., Guengerich, F.P., Tukey, R.H.K. and Kadlubar, F.F., Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis, 18, 851-854 (1997).
- Kidd, L.C., Stillwell, W.G., Wishnok, J.S., Skipper, P.L., Ross, R.K., Henderson, B.E. and Tannenbaum, S.R., Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)in White, African-American, and Asian-American men in Los Angeles County. Cancer Epidemiol. Biomarkers Prev., 8, 439-445 (1999).
- Layton, D.W., Bogen, K.T., Knize, M.G., Hatch, F.T., Johnson, V.M. and Felton, J.S., Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research. Carcinogenesis, 16, 39-52 (1995).
- Lin, D., Kaderlik, K.R., Turesky, R.J., Miller, D.W., Lay, J.O. and Kadlubar, F.F., Identification of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridinine, with DNA. Chem.Res.Toxicol., 5, 691-697 (1992).
- Lin, D.X., Lang, N.P. and Kadlubar, F.F., Species differences in the biotransformation of the food- borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Dispos., 23, 518-524 (1995).
- Lynch, A.M., Knize, M.G., Boobis, A.R., Gooderham, N.J., Davies, D.S. and Murray, S., Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline and 2-amino-1-methyl-6-phenylimidazo-(4,5-b)pyridine, carcinogens present in cooked beef. Cancer Res., 52, 6216-6223 (1992).
- Lynch, A.M., Murray, S., Boobis, A.R., Davies, D.S. and Gooderham, N.J., The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry. Carcinogenesis, 12, 1067-1072 (1991).
- Lynch, A.M., Murray, S., Zhao, K., Gooderham, N.J., Boobis, A.R. and Davies, D.S., Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin. Carcinogenesis, 14, 191-194 (1993).
- Manabe, S., Suzuki, H., Wada, O. and Ueki, A., Detection of the carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in beer and wine. Carcinogenesis, 14, 899-901 (1993).
- Manabe, S., Tohyama, K., Wada, O. and Aramaki, T., Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis, 12, 1945-1947 (1991).
- Pastorelli, R., Guanci, M., Cerri, A., Negri, E., La Vecchia, C., Fumagalli, F., Mezzetti, M., Cappelli, R., Panigalli, T., Fanelli, R. and Airoldi, L., Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol.Biomarkers Prev., 7, 703-709 (1998).
- Pastorelli, R., Restano, J., Guanci, M., Maramonte, M., Magagnotti, C., Allevi, R., Fanelli, R. and Airoldi, L., Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust. Carcinogenesis, 17, 2389-2394 (1996).
- Potter, J.D., Nutrition and colorectal cancer. Cancer Causes Control, 7, 127-146 (1996).
- Probst-Hensch, N.M., Sinha, R., Longnecker, M.P., Witte, J.S., Ingles, S.A., Frankl, H.D., Lee, E.R. and Haile, R.W., Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States). Cancer Causes Control, 8, 175-183 (1997).
- Reistad, R., Frandsen, H., Grivas, S. and Alexander, J., In vitro formation and degradation of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) protein adducts. Carcinogenesis, 15, 2547-2552 (1994).
- Reistad, R., Nyholm, S.H., Haug, L.S., Becher, G. and Alexander, J., 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human hair as biomarker for dietary exposure. Proc. Amer. Assoc. Cancer Res., 40, 151 (1999).
- Reistad, R., Rossland, O.J., Latva-Kala, K.J., Rasmussen, T., Vikse, R., Becher, G. and Alexander, J., Heterocyclic aromatic amines in human urine following a fried meat meal. Food Chem. Toxicol., 35, 945-955 (1997).
- Richling, E., Decker, C., Haring, D., Herderich, M. and Schreier, P., Analysis of heterocyclic aromatic amines in wine by high-performance liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogrphy A, 791, 71-77 (1997).
- Schut, H.A. and Snyderwine, E.G., DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis, 20, 353-368 (1999).
- Skipper, P.L. and Tannenbaum, S.R., Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis, 11, 507-518 (1990).
- Skog, K.I., Johansson, M.A. and Jagerstad, M.I., Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. Food Chem. Toxicol., 36, 879-896 (1998).
- Stillwell, W.G., Kidd, L.C., Wishnok, J.S., Tannenbaum, S.R. and Sinha, R., Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity. Cancer Res., 57, 3457-3464 (1997).
- Sugimura, T., Overview of carcinogenic heterocyclic amines. Mutat. Res., 376, 211-219 (1997).
- Turesky, R.J., Constable, A., Richoz, J., Varga, N., Markovic, J., Martin, M.V. and Guengerich, F.P., Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Chem. Res. Toxicol., 11, 925-936 (1998).
- Turesky, R.J., Skipper, P.L. and Tannenbaum, S.R., Binding of 2-amino-3-methylimidazo(4,5-f)quinoline to hemoglobin and albumin in vivo in the rat. Identification of an adducts suitable for dosimetry. Carcinogenesis, 8, 1537-1542 (1987).
- Vineis, P. and Mcmichael, A., Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control, 7, 479-486 (1996).
- Wakabayashi, K., Nagao, M., Esumi, H. and Sugimura, T., Food-derived mutagens and carcinogens. Cancer Res., 52 Suppl., 2092s-2098s (1992).
- Watkins, B.E., Esumi, H., Wakabayashi, K., Nagao, M. and Sugimura, T., Fate and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats. Carcinogenesis, 12, 1073-1078 (1991a).
- Watkins, B.E., Suzuki, M., Wallin, H., Wakabayashi, K., Alexander, J., Vanderlaan, M., Sugimura, T. and Esumi, H., The effect of dose and enzyme inducers on the metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in rats. Carcinogenesis, 12, 2291-2295 (1991b).
- World Health Organization. PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and micotoxins. 229-242Lyon, IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 56, pp. 229-242. IARC Lyon, France 1993).